Anupco


MULTIVIT INJECTION

Solution for Injection

COMPOSITION

Vitamin A 15,000 IU – Vitamin D3 1,000 IU – Vitamin E 20 mg – Vitamin B1 10 mg -Vitamin B1 10 mg – Vitamin B2 5 mg – Vitamin B6 3 mg – Vitamin B12 50 µg – Nicotinamide 35 mg – Pantothenol 25 mg/ml.

PHARMACOLOGICAL PROPERTIES

MULTIVIT injection is an aqueous emulsion for intramuscular or subcutaneous injection in animals that contains a mixture of fat soluble vitamins (A, D3 and E) and water soluble vitamins (B1, B2, B3, B5, B6, B12).

The fat soluble vitamins are necessary for the normal development and maintenance of the epithelial tissues and the skeletal system in animals. Vitamin B complex provides the essential prosthetic groups of the enzymes which control the catabolic and anabolic processes of carbohydrates, proteins and fats.

INDICATIONS

MULTIVIT INJECTION is indicated for the prevention and treatment of multiple vitamin deficiencies in animals.

Multiple vitamin deficiencies can occur in conditions of insufficient uptake (e.g. anorexia in case of illness, inadequate diets), insufficient absorption (e.g. in case of diarrhoea and malabsorbtion), and in any condition that results in physiologically increased requirements (growth, high milk production, pregnancy), disease, convalescence and stress conditions.

CONTRA-INDICATIONS

MULTIVIT INJECTION must not be administered via intravenous injection.

DOSAGE AND MODE OF ADMINISTRATION

By intramuscular or subcutaneous injection.

Horses and cattle: 20 to 30 ml

Calves, foals and sheep: 5 to 10 ml

Pigs and goats: 2 to 5 ml

Piglets up to 10kg: 0.5 to 2 ml

As a preventative measure the injection may be repeated every two or three months. For therapeutic purposes the injection can be given at shorter intervals, and repeated at intervals of 10 to 14 days.

UNDESIRABLE EFFECTS

None.

SPECIAL PRECAUTIONS FOR USE AND WARNINGS

None.

PACK SIZE

100ml and 250 ml multi-dose vials.

Please be aware that product specifications and availability can differ between countries. For detailed information in this regard, please contact us.

You are viewing the English version of this website enesfr